Dora Cobrinik

Internal Medicine physician in Philadelphia, Pennsylvania — also lists obesity medicine in the CMS registry.

Practice Details

Address
833 Chestnut St Ste 220
Philadelphia, PA 19107
Geocoded location: 39.9498, -75.1551
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2020
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
June 2023

Specialty taxonomies on file (2)

  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Dora Cobrinik is an Internal Medicine physician in Philadelphia whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 2911 Internal Medicine practices in Philadelphia carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Dora Cobrinik's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 215-955-8465.

GLP-1 access in Philadelphia, Pennsylvania

Adult obesity rate
33.4%
#20 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$209/mo
Typical Pennsylvania telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Pennsylvania Medicaid, obesity indication

About 33.4% of Pennsylvania adults have obesity (BMI 30+), ranking the state #20 of 50 (CDC BRFSS). Our directory currently lists 206 GLP-1-relevant clinics in Philadelphia. If a cash-pay route makes more sense, compounded semaglutide through Pennsylvania telehealth averages about $209/mo — well below brand-name Wegovy or Zepbound.

Explore more Pennsylvania options on the best Pennsylvania GLP-1 providers page, browse every Philadelphia listing in the Philadelphia clinic directory, or read the Pennsylvania Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Philadelphia

Other Philadelphia listings in the same directory tier:

Caroline Daroci
Nurse Practitioner, Acute Care
Juan Melendez Rivera
Internal Medicine
Alana Homan
Nurse Practitioner

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Pennsylvania addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Pennsylvania telehealth partners:

Featured Partners · Philadelphia

Featured GLP-1 providers serving Philadelphia

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 176 GLP-1 providers serving Philadelphia ↓

See more Philadelphia options on the Philadelphia clinic directory, our Philadelphia GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Philadelphia obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Dora Cobrinik's specialty taxonomy but not the specific medications it prescribes or its current service menu. Dora Cobrinik is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 215-955-8465 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Dora Cobrinik's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Dora Cobrinik is located at 833 Chestnut St Ste 220, Philadelphia, PA 19107. The phone number listed in the registry is 215-955-8465. Its full record is public in the CMS National Provider registry under NPI 1245859800.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Dora Cobrinik is currently accepting new patients. Call the practice at 215-955-8465 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.